From Childhood to Adulthood: Disease Activity Trajectories in Childhood-Onset Systemic Lupus Erythematosus

被引:17
|
作者
Lim, Lily Siok Hoon [1 ,2 ]
Pullenayegum, Eleanor [3 ]
Feldman, Brian M. [3 ]
Lim, Lillian [3 ]
Gladman, Dafna D. [4 ]
Silverman, Earl D. [3 ]
机构
[1] Univ Manitoba, Winnipeg, MB, Canada
[2] Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] Hosp Sick Children SickKids, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
ACTIVITY INDEX 2000; PROLONGED REMISSION; COHORT; DAMAGE; OUTCOMES; SLE; CLASSIFICATION; DETERMINANTS; VALIDATION; FREQUENCY;
D O I
10.1002/acr.23319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. No previous study has studied the longitudinal disease course of childhood-onset systemic lupus erythematosus (cSLE). Our objectives are to assess distinguishable differences in disease activity trajectories in cSLE patients, determine baseline factors predictive of disease trajectory membership, and assess if the different disease activity trajectories are associated with different damage trajectories. Methods. This is a retrospective, longitudinal inception cohort of cSLE patients. Patients were followed from diagnosis as children, until they were adults. SLE disease activity was modeled as a latent characteristic, jointly using the Systemic Lupus Erythematosus Disease Activity Index 2000 and prednisone in a Bayesian growth mixture model. Baseline factors were tested for membership prediction of the latent classes of disease trajectories. Differences in damage trajectories by disease activity classes were tested using a mixed model. Results. A total of 473 patients (82% females), with median age at diagnosis of 14.1 years, were studied. We studied 11,992 visits (2,666 patient-years). We identified 5 classes of disease activity trajectories. Baseline major organ involvement, number of American College of Rheumatology criteria, and age at diagnosis predicted memberships into different classes. A higher proportion of Asians was in class 2 compared to class 5. Class 1 was associated with the most accrual of damage, while class 5 was associated with no significant damage accrual, even after 10 years. Conclusion. There are 5 distinct latent classes of disease trajectory in patients with cSLE. Membership within disease trajectories is predicted by baseline clinical and demographic factors. Membership in different disease activity trajectory classes is associated with different damage trajectories.
引用
收藏
页码:750 / 757
页数:8
相关论文
共 50 条
  • [21] Long-term Outcomes of Childhood-Onset Systemic Lupus Erythematosus in Adulthood
    Levy, Deborah M.
    Gunraj, Nadia
    Berard, Roberta A.
    Dent, Peter B.
    Pope, Janet E.
    Thorne, J. Carter
    Roth, Johannes
    Fidler, Wesley
    Berall, Murray
    Guttmann, Astrid
    Silverman, Earl D.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S198 - S198
  • [22] Retinal vasculitis: A reliable marker of disease activity in childhood-onset systemic lupus erythematosus
    Dominguez-Varela, I. A.
    Barrera-Sanchez, M.
    Diaz-Prieto, T.
    Rodriguez-Valdes, P. J.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2022, 45 (08): : E371 - E373
  • [23] Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus
    Priscila B. S. Medeiros
    Roberta G. Salomão
    Sara R. Teixeira
    Diane M. Rassi
    Luciana Rodrigues
    Davi C. Aragon
    Priscila G. Fassini
    Fábio V. Ued
    Rita C. Tostes
    Jacqueline P. Monteiro
    Virgínia P. L. Ferriani
    Luciana M. de Carvalho
    Pediatric Rheumatology, 19
  • [24] Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus
    Medeiros, Priscila B. S.
    Salomao, Roberta G.
    Teixeira, Sara R.
    Rassi, Diane M.
    Rodrigues, Luciana
    Aragon, Davi C.
    Fassini, Priscila G.
    Ued, Fabio V.
    Tostes, Rita C.
    Monteiro, Jacqueline P.
    Ferriani, Virginia P. L.
    de Carvalho, Luciana M.
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [25] DISEASE ACTIVITY INDEX IS ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Medeiros, Priscila
    Salomao, Roberta Garcia
    Rassi, Diane Meyre
    Roberti, Luciana Rodrigues
    Teixeira, Sara Reis
    Fassini, Priscila Giacomo
    Tostes, Rita de Cassia
    Monteiro, Jacqueline Pontes
    Ferriani, Virginia
    de Carvalho, Luciana Martins
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1975 - 1976
  • [26] Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus
    Sakamoto, Ana P.
    Silva, Clovis A.
    Islabao, Aline G.
    Novak, Glaucia, V
    Molinari, Beatriz
    Nogueira, Paulo K.
    Pereira, Rosa M. R.
    Saad-Magalhaes, Claudia
    Clemente, Gleice
    Piotto, Daniela P.
    Aikawa, Nadia E.
    Pitta, Ana C.
    Trindade, Vitor C.
    Appenzeller, Simone
    Carvalho, Luciana M.
    Rabelo-Junior, Carlos N.
    Fonseca, Adriana R.
    Sztajnbok, Flavio R.
    Santos, Maria C.
    Bica, Blanca E.
    Sena, Evaldo G.
    Moraes, Ana J.
    Fraga, Melissa M.
    Robazzi, Teresa C.
    Spelling, Paulo F.
    Scheibel, Iloite M.
    Cavalcanti, Andre S.
    Matos, Erica N.
    Guimaraes, Luciano J.
    Santos, Flavia P.
    Mota, Licia M. H.
    Bonfa, Eloisa
    Terreri, Maria T.
    PEDIATRIC NEPHROLOGY, 2023, 38 (06) : 1843 - 1854
  • [27] Rituximab therapy for childhood-onset systemic lupus erythematosus
    Haddad, E
    Willems, M
    Niaudet, P
    Koné-Paut, I
    Bensman, A
    Cochat, P
    Deschênes, G
    Fakhouri, F
    Leblanc, T
    Llanas, B
    Loirat, C
    Pillet, P
    Salomon, R
    Ulinski, T
    Bader-Meunier, B
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 390 - 390
  • [28] Clinicopathology of childhood-onset renal systemic lupus erythematosus
    Olowu, W.
    Adelusola, K.
    Senbanjo, I.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1619 - 1619
  • [29] An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus
    Vitor Cavalcanti Trindade
    Magda Carneiro-Sampaio
    Eloisa Bonfa
    Clovis Artur Silva
    Pediatric Drugs, 2021, 23 : 331 - 347
  • [30] PREDICTORS OF MORTALITY IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Gacem, O.
    Zeroual, Z.
    Arrada, Z.
    Achir, Moussa
    Ladj, M. S.
    RHEUMATOLOGY, 2021, 60